Szmajda-Krygier Dagmara

19PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Preventative health careEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Feb 13, 2026
Advances in the Treatment of Ulcerative Colitis-From Conventional Therapies to Targeted Biologics and Small Molecules.

Aleksandra Wilk, Mateusz Pawłowski, Ewa Balcerczak

|Jan 30, 2026
In Silico and Wet Analysis of BAX Gene G-248A Polymorphism and mRNA Expression in Peptic Ulcer Disease and Gastric Cancer.

Marta Żebrowska-Nawrocka, Rafał Świechowski, Dagmara Szmajda-Krygier

|Sep 27, 2025
Monoclonal Antibodies: Historical Perspective and Current Trends in Biological Drug Development.

Barbara Madej, Filip Tomaszewski, Dagmara Szmajda-Krygier

|Feb 13, 2025
Assessment of Methylation in Selected ADAMTS Family Genes in Non-Small-Cell Lung Cancer.

Dagmara Szmajda-Krygier, Zuzanna Nocoń, Jacek Pietrzak

|Dec 13, 2024
Altered carnitine transporter genes (SLC22A5, SLC22A16, SLC6A14) expression pattern among lung cancer patients.

Konrad Kędzia, Dagmara Szmajda-Krygier, Adrian Krygier

Pageof 4